创新药板块火热，多只医药主题基金提前结束募集

Group 1 - The innovative drug sector has been experiencing a significant rally, creating opportunities for several pharmaceutical-themed funds currently in fundraising [1][3] - The Dongfang Alpha Health Industry Fund, which started fundraising on June 6, 2023, initially planned to end on June 13 but closed early on June 10 after just four trading days, indicating a shift in the trend for young fund managers [1] - The fund is managed by a relatively inexperienced manager, Meng Yu, who has less than two years of public fund management experience, breaking the previous norm of difficulties in fundraising for new funds led by young managers [1] Group 2 - On June 10, 2023, the Ping An Fund's Ping An Hong Kong Stock Connect Medical Innovation Selected Fund also announced an early closure, originally set to end on June 25, indicating a favorable market for new fund entries [3] - The fund is co-managed by Zhou Sicong and Zhang Miao, with Zhou's other fund, Ping An Core Advantage, achieving a cumulative return of 73% this year, heavily invested in the innovative drug sector [3] - Industry insiders suggest that new funds must seize favorable market entry points, as some funds have previously suffered significant losses due to high entry points, impacting the reputation of fund companies and future product issuance [3]